ライフサイエンスコーパス: fellow

1 ttle is known about burnout among nephrology fellows.

2 cian and 57 cases were performed by 6 cornea fellows.

3 nced educational experience of residents and fellows.

4 d practice providers with physician resident/fellows.

5 xperienced echocardiographers and cardiology fellows.

6 d educational resources used by programs and fellows.

7 Pulmonary/critical care fellows.

8 lem, including surveys of current and former fellows.

9 anic underrepresented minority critical care fellows.

10 ated burnout in abdominal transplant surgery fellows.

11 ience and emotional well being of nephrology fellows.

12 7/43; 86.0%) but residents (8/42; 18.6%) and fellows (7/43; 16.3%) were not.

13 ologists (57%; P < .001), and neuroradiology fellows (77%; P = .003).

14 ct as an endocrine disruptor as reported for fellow analgesics paracetamol and aspirin.

15 iption as well as image review by a research fellow and by a fellowship-trained abdominal radiologist

16 el, there were in-hospital residents, with a fellow and faculty member available at nighttime by phon

17 One-hundred eighty-seven fellows and 47 program directors participated.

18 burnout in pediatric critical care medicine fellows and examine factors that may contribute to or pr

19 of work done at home was different for both fellows and faculty (0.1 [< 0.1] intervention vs 1.0 [0.

20 Fellows and faculty completed diaries detailing their sl

21 eep time (mean hours [SD]) was increased for fellows and faculty in the intervention versus control (

22 institutions will find it difficult to train fellows and introduce the field of A/I to medical studen

23 Pediatric critical care medicine fellows and program directors.

24 st study to evaluate pulmonary critical care fellows' and intensivists' use of goal-directed echocard

25 s that included 2 residents, 6 vitreoretinal fellows, and 4 vitreoretinal attending physicians.

26 Roles included 41.1% residents, 5.0% fellows, and 53.9% faculty.

27 idents, general radiologists, neuroradiology fellows, and academic neuroradiologists by using accurac

28 vs 82.8% vs 80.3%; p = 0.26) for attendings, fellows, and residents/nurse practitioners, respectively

29 pital of Philadelphia and as Senior Research Fellow at the Institute of Virology in Wurzburg, Germany

30 l as training level and PR experience of the fellow at the time of the procedure.

31 The exclusion of fellows at 30% of the programs may have over or underest

32 ted with patient payout, while a resident or fellow being named in a claim was negatively associated

33 choice (beta 9.319; p <= 0.0001), spiritual fellows (beta 1.651; p = 0.0286), those with a stress ou

34 .0067), those who perceived burnout among co-fellows (beta 1.803; p = 0.0352), and those from ICUs wi

35 Depersonalization was higher for second year fellows (beta 2.034; p = 0.0482), those with less educat

36 se comfortable seeking support from their co-fellows (beta 3.762; p = 0.0006).

37 3), and those who perceived burnout among co-fellows (beta 5.698; p <= 0.0001).

38 % use a checklist-based tool when evaluating fellow central venous catheter placement competence unde

39 ted himself to his students, colleagues, and fellow chemists with an aura of nobility and romanticism

40 take during the COVID-19 pandemic to support fellow clinicians.

41 ar age-related macular degeneration (AMD) or fellow control eyes, as well as analyze risk factors for

42 skan Native/Native Hawaiian/Pacific Islander fellows decreased from 15 (1.0%) to seven (0.3%) (p < 0.

43 Residents and fellows employed by Accreditation Council on Graduate Me

44 at burnout rates are relatively low, but few fellows engage in self-care.

45 inal tear (1 eye), and history of RRD in the fellow eye (1 eye).

46 ye (AE) loses visual sensitivity whereas the fellow eye (FE) is largely unaffected.

47 als from the AE by signals from its dominant fellow eye (FE).

48 out CNV in the study eye and CNV+/-GA in the fellow eye (fellow eye CNV cohort, n = 168) or GA withou

49 thout CNV in the study eye, no CNV/GA in the fellow eye (fellow eye intermediate AMD cohort, n = 32).

50 y of mesopic vision in the apparently normal fellow eye (forme fruste) to detect the earliest and mos

51 e, choroidal neovascularization (CNV) in the fellow eye (GA:CNV); GA in 1 eye with early or intermedi

52 1 eye with early or intermediate AMD in the fellow eye (GA:E); and early/intermediate AMD in both ey

53 g knowledge about the level of damage in the fellow eye (P > 0.61).

54 y by incorporating rate information from the fellow eye (P < 0.05), but not by incorporating knowledg

55 history of SRT or retinal detachment in the fellow eye (p = 0.13).

56 otherapy (CCRT) prevented involvement of the fellow eye 1 year after symptom onset.

57 rly/intermediate AMD, with the status of the fellow eye affecting the rate of progression.

58 n in an eye is more likely to be real if the fellow eye also seems to be progressing rapidly.

59 one eye and forme fruste keratoconus in the fellow eye and 72normal subjects were evaluated.

60 t on delaying progression to late AMD in the fellow eye and did not, in general, have an impact on th

61 d in OCT or fundus photographs; by using the fellow eye as a control, this grading scale can be used

62 ked potential (FF-VEP) versus the unaffected fellow eye at baseline.

63 s or phenotypes associated with atrophy were fellow eye atrophy, reticular pseudodrusen, increased in

64 ion enlargement, including both affected and fellow eye characteristics.

65 Prospective, randomized, controlled fellow eye clinical study.

66 ral GA (Proxima A), 3.55 (0.16) mm(2) in the fellow eye CNV cohort (Proxima B), and 2.96 (0.25) mm(2)

67 , -9.49 (1.29) and -7.57 (1.26) in Proxima B fellow eye CNV cohort, and -11.48 (3.39) and -8.37 (3.02

68 he study eye and CNV+/-GA in the fellow eye (fellow eye CNV cohort, n = 168) or GA without CNV in the

69 This prospective, 9-year fellow eye comparison study suggests that an inexpensive

70 of translation factors, the datasets in each fellow eye group fit along a straight line with a high r

71 In the fellow eye group, VA, CMT, and all choroidal parameters

72 lattice degeneration in an eye in which the fellow eye had a history of RD resulted in $4414/QALY ($

73 the presence of macular complications in the fellow eye had an HR of 20.17 (95% CI: 1.34-39.41; P = .

74 these findings, with odds increasing if the fellow eye had baseline intralesional MA (OR, 2.43; 95%

75 ge-related macular degeneration (AMD) in the fellow eye has been used as an indicator of the GA progr

76 presentation (so called unilateral KC), the fellow eye has the mildest and earliest form of the dise

77 h 12, the difference between study eye minus fellow eye improvement in group 2 patients of 0.53 logMA

78 h 18, the difference between study eye minus fellow eye improvement in our acute group 2 gene therapy

79 se, pupil size was also measured once in the fellow eye in a total of 75 eyes.

80 regarding an increased risk of PCSON in the fellow eye in patients who have experienced it or sponta

81 Foveal floor width of the fellow eye in patients with a unilateral idiopathic MH w

82 ence of neovascularization in the unaffected fellow eye increases with time, and when the first eye i

83 rt (Proxima B), and 2.96 (0.25) mm(2) in the fellow eye intermediate AMD cohort (Proxima B).

84 the study eye, no CNV/GA in the fellow eye (fellow eye intermediate AMD cohort, n = 32).

85 -11.48 (3.39) and -8.37 (3.02) in Proxima B fellow eye intermediate AMD cohort, respectively.

86 The RNFL thickness difference (fellow eye minus injected eye) was significantly correla

87 The fellow eye no longer aided predictions for n = 5 or 6 fi

88 Conversion to GA or CNV in the fellow eye occurred in 30% and 6.7% of participants, res

89 The fellow eye of 1 patient had RD due to peripheral breaks.

90 Our report demonstrates that the fellow eye of a patient with PCG may be at risk of sudde

91 condary outcome was the risk of PCSON in the fellow eye of patients with prior unilateral spontaneous

92 r 1 hour per day (n = 40) or patching of the fellow eye prescribed for 2 hours per day (n = 60).

93 termediate AMD and a diagnosis of CNV in the fellow eye progressed to CNV fastest (at a rate of 15.2

94 rs), and those with a diagnosis of GA in the fellow eye progressed to GA fastest (11.2 per 100 person

95 riphery of the inlay while the corresponding fellow eye projected pupil alternated between 0 and 3.0

96 Systematic review and meta-analysis of how fellow eye status predicts the progression rate of geogr

97 n location, multifocality, FAF patterns, and fellow eye status.

98 Three fellow eye statuses were analyzed: (1) no GA or choroida

99 og-rank test was used to compare CNV and RAP fellow eye survival.

100 Hs, we examined the foveal floor size of the fellow eye to evaluate its relationship with idiopathic

101 nsmittance of the pupil corresponding to the fellow eye until the perceived flickering, owing to the

102 Geographic atrophy (GA) in the fellow eye was associated with increased risk of macular

103 time of absence of neovascularization in the fellow eye was calculated.

104 Survival of the fellow eye was estimated by Kaplan-Meier analysis, and l

105 ickness measurements of the injected eye and fellow eye were 87.3 +/- 9.6 mum and 89.0 +/- 7.5 mum, r

106 one eye and forme fruste keratoconus in the fellow eye were compared to subjects with normal eyes.

107 condary to eAMD in 1 eye with neAMD in their fellow eye were identified.

108 and without signs of neovascular AMD in the fellow eye were included in the analysis.

109 (57 eyes, VAE-E group), and the nonoperated fellow eye with normal topography (57 eyes, VAE-NT group

110 1 eye and demonstrated acute hydrops in the fellow eye within 1 week.

111 f variance to determine if incorporating the fellow eye's level of visual field damage (MD) or rate s

112 coefficient quantifying the influence of the fellow eye's rate changed relatively little for n = 3 to

113 ymmetrical disease (primary angle closure in fellow eye) were analyzed.

114 or choroidal neovascularization (CNV) in the fellow eye, (2) GA in the fellow eye, and (3) CNV in the

115 ation (CNV) in the fellow eye, (2) GA in the fellow eye, and (3) CNV in the fellow eye.

116 tive AMD in one eye and exudative AMD in the fellow eye, and 8 age-matched control subjects.

117 radings of both eyes, current grading of the fellow eye, and demographic data.

118 matous proliferation (RAP) lesion, GA in the fellow eye, and intraretinal fluid were associated with

119 L growth was analyzed relative to treated vs fellow eye, contact lens (CL) vs intraocular lens (IOL),

120 med that the presence of advanced AMD in the fellow eye, defined as GA or CNV, can serve as a biomark

121 ye is, in part, predicted by the rate in the fellow eye, particularly when only a few visual field re

122 The fellow eye, without advanced AMD, was selected for the s

123 Prospective, fellow eye-matched case series.

124 aucoma or poor VA often grew longer than the fellow eye.

125 by subgroup, based on the AMD status of the fellow eye.

126 ization in the treated eye compared with the fellow eye.

127 mplanted, in comparison with their untreated fellow eye.

128 e, or the refractive error in the treated or fellow eye.

129 eye and wavefront-guided (WFG) LASIK in the fellow eye.

130 and fellow eyes and with RPE changes in the fellow eye.

131 , he suffered another attack of NAION in the fellow eye.

132 th the small aperture in comparison with the fellow eye.

133 (2) GA in the fellow eye, and (3) CNV in the fellow eye.

134 atrophy/fibrotic scar/neovascular AMD in the fellow eye.

135 ndard deviation, 9.0 letters correct) in the fellow eye.

136 t may help to prevent this phenomenon in the fellow eye.

137 fined foveal pit morphologic features of the fellow eye.

138 can improve the estimate of the rate in the fellow eye.

139 fellow-eye comparative case series METHODS STUDY POPULAT

140 patients demonstrating unilateral ARN showed fellow-eye involvement after initiation of therapy.

141 a, multicenter, open-label, dose-escalation, fellow-eye-controlled study.

142 ye with vision the same as or worse than the fellow-eye.

143 lower progression rate in study eyes than in fellow eyes (0.29 +/- 0.58 mm vs. 1.08 +/- 0.65 mm; P =

144 total GA area at month 12 between study and fellow eyes (1.07 +/- 0.84 mm(2) vs. 2.08 +/- 1.97 mm(2)

145 rated a greater proportion of RPE changes in fellow eyes (30.8% vs. 1.7%; P = 0.03) and significantly

146 er values of corneal hysteresis and CRF than fellow eyes (9.0 +/- 1.8 vs 10.1 +/- 1.8 mm Hg, respecti

147 mm Hg in topical bimatoprost-treated pooled fellow eyes (data censored at rescue/retreatment).

148 (retinal detachment eyes, RDE) and 5 healthy fellow eyes (HFE) of 5 patients (mean age 59.8 years, ma

149 Fellow eyes (n = 207) were treated with 5-minute dosing

150 monthly (n = 19), TREX (n = 30), and control fellow eyes (n = 39).

151 , 46% and 60% of values obtained from normal fellow eyes (P < 0.004).

152 was -2.25 D (IQR -5.13, +0.88 D) and of the fellow eyes +1.50 D (IQR +0.88, +2.25).

153 om effects to adjust for correlation between fellow eyes and repeated measures within eyes.

154 ubfoveal choroidal thickness in surgical and fellow eyes and with RPE changes in the fellow eye.

155 For fellow eyes before injection, it was 56 mum, decreasing

156 itudes worsened more in treated eyes than in fellow eyes by approximately 0.05 muV (P = 0.009 exchang

157 Of the 635 study and fellow eyes examined at 6 months, 134 (21%) gained and 3

158 (0.102 +/- 0.062 mm/year) than in eyes whose fellow eyes never demonstrated GA during follow-up (0.06

159 From 24 fellow eyes of 24 patients with unilateral RVO (15 men a

160 types of acute angle closure and compared to fellow eyes of AAC and PACS eyes.

161 (96 patients) consisting of 71 AAC eyes, 71 fellow eyes of AAC, and 25 PACS eyes were recruited.

162 clinical nonexudative neovascular AMD in the fellow eyes of patients with unilateral exudative AMD ra

163 .5-mm scans in 35 healthy eyes (asymptomatic fellow eyes of patients with unilateral retinal conditio

164 Small resolved PAMM lesions in fellow eyes of patients with unilateral RVO are most pre

165 n complex layer becomes thinner over time in fellow eyes of subjects with unilateral neovascular AMD.

166 ve CNV frequently is detected by OCTA in the fellow eyes of those with exudative CNV.

167 The OCT sessions for fellow eyes of unilateral retinoblastoma without any sus

168 significantly different between treated and fellow eyes preoperatively (18.1 vs. 18.7 mm, P < 0.0001

169 treatment and was considered the study eye; fellow eyes served as controls.

170 d growth rate was 50.0% higher in eyes whose fellow eyes showed GA at any visit (0.102 +/- 0.062 mm/y

171 The rate of GA area growth in study and fellow eyes was analyzed by linear regression of square-

172 Drusen distribution in 23 fellow eyes was detected as followed: drusen < 63 mum in

173 rements between injected eyes and uninjected fellow eyes was largely within the reported normal limit

174 et membrane endothelial keratoplasty, and 71 fellow eyes were enrolled and assigned to the opposite t

175 n variability as well as differences between fellow eyes were evaluated.

176 ronic CSCR treated with PDT and 64 untreated fellow eyes were evaluated.

177 Fellow eyes were modeled separately.

178 Fluorescein angiograms of the affected and fellow eyes were reviewed by 2 authors for characteristi

179 clinical trial dataset that includes 671 AMD fellow eyes with 13,954 observations before any signs of

180 low eyes with GA (0.179+/-0.003 mm/year) and fellow eyes with CNV (0.159+/-0.015 mm/year) was signifi

181 growth rates between fellow eyes with GA and fellow eyes with CNV (P = 0.42).

182 an-Meier analysis showed that the 50% of the fellow eyes with CNV did not develop neovascularization

183 The GA radius growth rate in fellow eyes with GA (0.179+/-0.003 mm/year) and fellow e

184 erence in the GA radius growth rates between fellow eyes with GA and fellow eyes with CNV (P = 0.42).

185 The control group included 147 fellow eyes with no prior intravitreal injections.

186 zation for 5.3 years, whereas the 50% of the fellow eyes with RAP did not develop neovascularization

187 /year) was significantly higher than that in fellow eyes without GA or CNV (0.110+/-0.009 mm/year; P

188 th NA-AION, 51% had ODD-AION, whereas 43% of fellow eyes without NA-AION had ODD (P = .36).

189 In fellow eyes, an established nAMD lesion was present at b

190 Concerning the comparative analysis between fellow eyes, no statistically significant differences in

191 2) (SD, 172 cells/mm(2)) in the surgical and fellow eyes, respectively (P = 0.92), and compared with

192 However, in fellow eyes, the increase in ACA was mainly owing to dec

193 Z area between eyes with melanoma and normal fellow eyes.

194 ilateral PFV were present in the majority of fellow eyes.

195 ation from the surgical and the glaucomatous fellow eyes.

196 compared with baseline and with glaucomatous fellow eyes.

197 .8 mm Hg, respectively; P = .022) but not in fellow eyes.

198 treatment, which were compared with healthy fellow eyes.

199 baseline and after treatment, as well as in fellow eyes.

200 AAU eyes at baseline and after treatment and fellow eyes.

201 espectively, and in 3.3% (1/30; for both) of fellow eyes.

202 in PGA-treated eyes compared with untreated fellow eyes.

203 ving faster during A2 in the OEs than in the fellow eyes.

204 ps and also kept pace with the growth of the fellow eyes.

205 m in affected eyes and 152 +/- 41 mum in the fellow eyes.

206 Abnormalities on FA were seen in 31 (75.6%) fellow eyes: peripheral vessel avascularity in 27.5 (67.

207 tinal detachment eyes, RDE) and five healthy fellow-eyes (HFE) of five patients (mean age 59.8 years,

208 There is significant risk of a fellow failing to meet case minimums in the ACGME system

209 n distributions, probabilities of individual fellows failing to meet minimum case numbers were calcul

210 excellent" (44%), and most (55%) second-year fellows felt "fully prepared" for independent practice.

211 is national analysis of abdominal transplant fellows found that burnout rates are relatively low, but

212 Fellows from 30% of programs were excluded due to lack o

213 In 2 years of the fellowship, fellows generally achieved the productivity metrics soug

214 about losing vision from glaucoma than their fellow glaucoma patients with less severe or no visual f

215 teral glaucoma or unilateral glaucoma with a fellow glaucoma suspect eye were enrolled.

216 ers who were told their opponent was another fellow human, compared to those who were told it was a c

217 nd suffering that the catastrophes cause for fellow humans, rather than on the long-term consequences

218 amination findings by the senior resident or fellow in 59 encounters (24.0%) and shorter follow-up ti

219 tion of out-group, anonymized-group and even fellow in-group members' perceptions.

220 was sent to all abdominal transplant surgery fellows in an American Society of Transplant Surgeons-ac

221 ology annual survey emailed to US nephrology fellows in May to June 2018.

222 mmary case logs were obtained for graduating fellows in pediatric surgery from 2008 to 2018.

223 n and alertness were improved in faculty and fellows in the intervention staffing model.

224 Pediatric critical care medicine fellows in the United States are experiencing high level

225 In group II of 4 fellows in training, sensitivity was 91+/-2%, and specif

226 Second-year U.S. vitreoretinal surgery fellows in two-year training programs were invited to pa

227 trainees (graduate students and postdoctoral fellows) in academic science from historically underrepr

228 pedagogical model, with outcomes for the 12 fellows including 50 AF-related manuscripts, 7 publicati

229 om 2004 to 2014, the number of critical care fellows increased annually, up 54.1% from 1,606 in 2004-

230 The absolute number of black fellows increased each year but the percentage change wa

231 ogists and two interventional neuroradiology fellows, independently reviewed the CT angiography image

232 Most fellows indicated having strong program leadership (75.2

233 medication (OR 3.34; 95% CI: 1.94-5.73), and fellow involvement (OR 2.20; 95% CI: 1.31-3.71) were ass

234 male gender (OR 3.50; 95% CI: 1.37-8.94) and fellow involvement (OR 4.15; 95% CI: 1.79-9.58) were ass

235 ew of the available images, a neuroradiology fellow (M.D.M.) performed history taking and a physical

236 contributions and training of residents and fellows may also synergistically work to impress to hosp

237 ed and applicable education to residents and fellows may have long-term, strategic, positive impacts

238 Procedure experience of individual fellows may impact anatomic outcomes.

239 e providers compared with physician resident/fellows measured as length of stay or mortality.

240 experiences where obligations are held among fellow members of a group "we."

241 ate was 59.2% (n = 77) and 22.7% (n = 17) of fellows met criteria for burnout.

242 mplishment was greater (lower burnout) among fellows more satisfied with their career choice (beta 9.

243 twork was better than that of neuroradiology fellows (n = 2) for T3DDx (72%; P = .003) but not for TD

244 inician staffing included residents (n = 9), fellows (n = 4), and nurse practitioners or physician as

245 mary surgeons were residents (n = 142, 28%), fellows (n = 88, 18%), and consultants (n = 270, 54%).

246 tatic eye of the VAE cohort, relative to the fellow non-ectatic eye (p <= 0.008 for all).

247 ery was significantly higher compared to the fellow (not-operated) eyes (p < 0.001).

248 describing overnight staffing by residents, fellows, nurse practitioners, and staff physicians, as w

249 for Services to Science in 2011 and became a Fellow of the Royal Society in 2015.

250 Pathology at the University of Oxford and a fellow of the Royal Society.

251 providers on the ICU and physician residents/fellows on the ICU, suggesting the quality of care of bo

252 fellows, reductions in total work hours for fellows only, and improvements in subjective well-being

253 s catheter placement training for first-year fellows, only 42% of programs provide ongoing maintenanc

254 92 cases (38%) as high-risk, recommended for fellows or consultants (attendings).

255 ration did not differ between the models for fellows or faculty.

256 Physicians (29 fellows or residents, eight attending neurologists) eval

257 s have support systems in place for minority fellows or specific gender groups, including procedures

258 RVO and OCT evidence of resolved PAMM in the fellow, otherwise normal, eye were recruited prospective

259 Twenty-one fellows participated in the study (simulation, 10; tradi

260 ers of the Johns Hopkins Hospital along with fellow Penn faculty member, Howard Kelly.

261 In conclusion, current nephrology fellows perceive several gaps in training.

262 ch appears to be influenced by demographics, fellow perceptions of their work environment, and satisf

263 This study assessed fellows' perceptions of current educational needs and in

264 Vitreoretinal fellows perform variably few pneumatic retinopexies but

265 Pulmonary Critical Care Medicine Fellows performed 154 goal-directed echocardiograms, 110

266 Vitreoretinal fellows performed a variable number of PR, with a median

267 Pulmonary critical care fellows performed and documented their goal-directed ech

268 Participating residents and fellows performed tasks faster (DOME and DVSS groups) an

269 stitute, NIH; Howard Hughes Medical Research Fellows Program, Howard Hughes Medical Institute; Bill a

270 s trainees (medical students, residents, and fellows), provide professional development to primary ca

271 e number of PR, with a median of 7 cases per fellow (range 1-24).

272 halmologists, 4 retina specialists, 1 retina fellow) read images for DR severity based on the Interna

273 electronic survey to all United States-based fellows receiving complimentary American Society of Neph

274 ases in total sleep duration for faculty and fellows, reductions in total work hours for fellows only

275 ed practice providers and physician resident/fellows regarding the outcome measures of mortality, len

276 All fellows reported medium to high satisfaction with the ov

277 each patient, the clinical team (attending, fellow, resident/nurse practitioner) was surveyed regard

278 tion were reported by 28.0% and 14.4% of the fellows, respectively, with an overall burnout prevalenc

279 between the original report and the research fellow's assessment.

280 ze of retinal detachment (P = 0.02), and the fellow's procedure experience (P = 0.01).

281 create containers suitable for sharing with fellow scientists, for including in scholarly communicat

282 In group IV of 7 other fellows, sensitivity was 91+/-3%, and specificity was 92

283 year in conjunction with the ASN Nephrology Fellows Survey.

284 About one third of US nephrology fellows surveyed reported experiencing burnout and depre

285 ssment and decisions around the ability of a fellow to place a central venous catheter under indirect

286 s for success involve clear expectations for fellows to produce manuscripts, presentations, and-for t

287 rograms should develop interventions to give fellows tools to prevent and combat burnout.

288 surgeon (JMG) and 6 novice surgeons (cornea fellows under supervision) were reviewed.

289 of RNFL thinning in the injected versus the fellow uninjected eye.

290 es receiving intravitreal injections than in fellow uninjected eyes among patients suspected of havin

291 ns did not significantly differ from that of fellow uninjected eyes.

292 pare AL growth of operated eyes with that of fellow unoperated eyes.

293 on a lack of substantial IOP effects on the fellow untreated eye, compared to brimonidine twice-dail

294 Most fellows were aged 30-34 years (56.8%), male (62.0%), mar

295 ible first- and second-year adult nephrology fellows were examined (response rate=42.9%).

296 Average values on each burnout domain for fellows were higher than published values for other medi

297 acterize demographic trends in critical care fellows, who represent the emerging intensivist workforc

298 more likely to exhibit burnout compared with fellows with higher scores (3.6 vs 4.0, P = .026).

299 Fellows with lower grit scores were more likely to exhib

300 h ("body CT studies") committed by radiology fellows working off-hours based on day or night assignme